CORTESINI RAFFAELLO: "Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3)." JOP : JOURNAL OF THE PANCREAS 2007, vol. 8, no. 6, 1 November 2007 (2007-11-01), pages 697-703, XP002522044 ISSN: 1590-8577 (B1)

ISRAEL L ET AL: "Plasmapheresis and immunological control of cancer." LANCET 18 SEP 1976, vol. 2, no. 7986, 18 September 1976 (1976-09-18), pages 642-643, XP002522043 ISSN: 0140-6736 (B1)

ROGUSKA M A ET AL: "HUMANIZATION OF MURINE MONOCLONAL ANTIBODIES THROUGH VARIABLE DOMAIN RESURFACING", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US, vol. 91, 1 February 1994 (1994-02-01), pages 969-973, XP002917393, ISSN: 0892-6638 (B1)

SHARKEY ROBERT M ET AL: "Targeted therapy of cancer: new prospects for antibodies and immunoconjugates." CA: A CANCER JOURNAL FOR CLINICIANS 2006 JUL-AUG, vol. 56, no. 4, July 2006 (2006-07), pages 226-243, XP002522041 ISSN: 0007-9235 (B1)

TASSONE PIERFRANCESCO ET AL: "Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells." BLOOD 1 DEC 2004, vol. 104, no. 12, 1 December 2004 (2004-12-01), pages 3688-3696, XP002521112 ISSN: 0006-4971 (B1)

WO-A-2007/144046 (B1)

US-A1- 2005 272 128 (B1)

US-A1- 2007 183 971 (B1)

WO-A-2004/099379 (B1)

WO-A-2006/099875 (B1)

WO-A-2007/066109 (B1)

TURNER J HARVEY ET AL: "131I-Anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital." CANCER BIOTHERAPY & RADIOPHARMACEUTICALS AUG 2003, vol. 18, no. 4, August 2003 (2003-08), pages 513-524, XP002522042 ISSN: 1084-9785 (B1)